carbosin 150 mg inf. sol. (conc.) i.v. vial
teva pharma belgium sa-nv - carboplatin 10 mg/ml - concentrate for solution for infusion - 150 mg - carboplatin 10 mg/ml - carboplatin
stricarb 10 mg/ml (150 mg/15 ml) solution for infusion (iv)
mylan philippines inc. - carboplatin - solution for infusion (iv) - 10 mg/ml (150 mg/15 ml)
carboplatinum hikma farmacêutica 50 mg inf. sol. (conc.) i.v. vial
hikma farmacêutica s.a. - carboplatin 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - carboplatin 50 mg - carboplatin
carboplatinum hikma farmacêutica 150 mg inf. sol. (conc.) i.v. vial
hikma farmacêutica s.a. - carboplatin 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - carboplatin 150 mg - carboplatin
carboplatinum hikma farmacêutica 450 mg inf. sol. (conc.) i.v. vial
hikma farmacêutica s.a. - carboplatin 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - carboplatin 450 mg - carboplatin
carboplatin injection, solution
sagent pharmaceuticals - carboplatin (unii: bg3f62ond5) (carboplatin - unii:bg3f62ond5) - carboplatin 10 mg in 1 ml - carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. one established combination regimen consists of carboplatin and cyclophosphamide. two randomized controlled studies conducted by the ncic and swog with carboplatin versus cisplatin, both in combination with cyclophosphamide, have demonstrated equivalent overall survival between the two groups (see clinical studies ). there is limited statistical power to demonstrate equivalence in overall pathologic complete response rates and long-term survival (≥3 years) because of the small number of patients with these outcomes: the small number of patients with residual tumor <2 cm after initial surgery also limits the statistical power to demonstrate equivalence in this subgroup. carboplatin injection is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously trea
carboplatin 600mg/60ml concentrate for solution for infusion vials
accord-uk ltd - carboplatin - solution for infusion - 10mg/1ml
carboplatin 10mg/ml concentrate for solution for infusion concentrate for solution for infusion
accord healthcare polska sp. z o.o. - carboplatin - concentrate for solution for infusion - 10mg/ml
carboplatin 10mg/ml concentrate for solution for infusion concentrate for solution for infusion
accord healthcare polska sp. z o.o. - carboplatin - concentrate for solution for infusion - 10mg/ml
carboplatin 10mg/ml concentrate for solution for infusion concentrate for solution for infusion
accord healthcare polska sp. z o.o. - carboplatin - concentrate for solution for infusion - 10mg/ml